International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 5 , Pages 1377-1382 , 1 August 2011

Preoperative Chemoradiation for Rectal Cancer Using Capecitabine and Celecoxib Correlated With Posttreatment Assessment of Thymidylate Synthase and Thymidine Phosphorylase Expression

  • Keith R. Unger, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia
    • ,
  • Davis A. Romney, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia
    • ,
  • Mehmet Koc, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia
    • Department of Radiation Oncology, University of Selcuk, Konya, Turkey
    • ,
  • Christopher. A. Moskaluk, M.D.

      Affiliations

    • Department of Pathology, University of Virginia, Charlottesville, Virginia
    • ,
  • Charles M. Friel, M.D.

      Affiliations

    • Department of Surgery, University of Virginia, Charlottesville, Virginia
    • ,
  • E.F. Foley, M.D.

      Affiliations

    • Department of Surgery, University of Virginia, Charlottesville, Virginia
    • ,
  • Tyvin A. Rich, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia
    • Corresponding Author InformationReprint requests to: Tyvin A. Rich, M.D., Department of Radiation Oncology, University of Virginia, Charlottesville, VA, 22908. Tel: (434) 924-5551; Fax: (434) 243-9789

Received 26 June 2009 ,Revised 19 April 2010 ,Accepted 19 April 2010.

References 

  1. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin. 1993;43(1):7–26
  2. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997;336(14):980–987
  3. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–1740
  4. Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, et al. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2005;63(2):346–353
  5. Yerushalmi R, Idelevich E, Dror Y, Stemmer SM, Figer A, Sulkes A, et al. Preoperative chemo-radiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil. J Surg Oncol. 2006;93(7):529–533
  6. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue. Eur J Cancer. 1998;34(8):1274–1281
  7. Sawada N, Ishikawa T, Sekiguchi F, Tanaka Y, Ishitsuka H. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine in human xenografts. Clin Cancer Res. 1999;5:2948–2953
  8. Sawada N, Ishikawa T, Fukase Y, Nishida M, Yoshikubo T, Ishitsuka H. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clin Cancer Res. 1998;4(4):1013–1019
  9. Rich TA, Shepard R. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: Esophagus, stomach, and pancreas. Am J Clin Oncol. 2003;26(4):S110–S113
  10. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19–23
  11. Lin E, Morris JS, Ayers GD. Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology (Williston Park). 2002;16(12) (Suppl 14):31–37
  12. Smith FM, Reynolds JV, Kay EW, Crotty P, Murphy JO, Hollywood D, et al. COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys. 2006;64(2):466–472
  13. Lin EH, Curley SA, Crane CC, Feig B, Skibber J, Delcos M, et al. Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer. Am J Clinical Oncology. 2006;29(3):232–239
  14. Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, et al. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2005;63(2):346–353
  15. Yerushalmi R, Idelevich E, Dror Y, Stemmer SM, Figer A, Sulkes A, et al. Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil. J Surg Oncol. 2006;93(7):529–533
  16. Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand HS, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Breast and Bowel Project protocol R-03. Dis Colon Rectum. 1997;40(2):131–139
  17. Jakob C, Liersch T, Meyer W, Baretton GB, Häusler P, Schwabe W, et al. Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy. Am J Surg Pathol. 2005;29(10):1304–1309
  18. Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, et al. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. J Clin Oncol. 2006;24(25):4062–4068
  19. Popat S, Matakidou A, Houlston RS. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2004;22(3):529–536
  20. Edler D, Hallström M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H. Thymidylate synthase expression: An independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res. 2000;6(4):1378–1384
  21. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, et al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol. 1997;15(10):3223–3229
  22. Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, et al. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res. 1998;4(10):2371–2376
  23. Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Häusler P, et al. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumor regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. J Pathol. 2004;204(5):562–568
  24. Stoehlmacher J, Goekkurt E, Mogck U, Aust DE, Kramer M, Baretton GB, et al. Thymidylate synthase genotypes and tumor regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation. Cancer Lett. 2008;272(2):221–225
  25. Blanquicett C, Saif MW, Buchsbaum DJ, Eloubeidi M, Vickers SM, Chhieng DC, et al. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: Clinical implications of abscopal effects. Clin Cancer Res. 2005;11:(24)(Pt 1):8773–8781.
  26. Angelita Habr-Gama. Personal communication, 2010.

 Conflict of interest: none.

PII: S0360-3016(10)00589-4

doi: 10.1016/j.ijrobp.2010.04.016

International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 5 , Pages 1377-1382 , 1 August 2011

Article Tools

* Image Usage & Resolution